Eyebright Total Assets vs Cash And Short Term Investments Analysis

688050 Stock   90.61  1.90  2.05%   
Eyebright Medical financial indicator trend analysis is much more than just examining Eyebright Medical latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eyebright Medical is a good investment. Please check the relationship between Eyebright Medical Total Assets and its Cash And Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Assets vs Cash And Short Term Investments

Total Assets vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Eyebright Medical Total Assets account and Cash And Short Term Investments. At this time, the significance of the direction appears to have totally related.
The correlation between Eyebright Medical's Total Assets and Cash And Short Term Investments is 0.99. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Eyebright Medical Technology, assuming nothing else is changed. The correlation between historical values of Eyebright Medical's Total Assets and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Eyebright Medical Technology are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Total Assets i.e., Eyebright Medical's Total Assets and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.99
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Assets

Total assets refers to the total amount of Eyebright Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Eyebright Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Eyebright Medical balance sheet. This account contains Eyebright Medical investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Eyebright Medical Technology fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Eyebright Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eyebright Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Selling General Administrative is expected to grow to about 226.9 M, whereas Tax Provision is forecasted to decline to about 25.8 M.
 2021 2022 2023 2024 (projected)
Interest Expense736.9K2.0M9.8M10.3M
Depreciation And Amortization42.0M58.7M67.5M70.9M

Eyebright Medical fundamental ratios Correlations

0.960.320.930.910.96-0.610.960.870.860.970.740.990.840.920.940.250.880.930.87-0.350.960.910.340.80.96
0.960.460.860.920.88-0.690.890.760.890.890.750.950.770.850.820.370.90.860.9-0.310.880.890.370.720.96
0.320.460.00.560.11-0.580.14-0.150.530.120.590.320.110.1-0.020.570.590.050.65-0.20.080.50.61-0.050.44
0.930.860.00.740.99-0.350.980.980.680.990.580.920.850.980.970.010.681.00.65-0.280.980.740.170.860.87
0.910.920.560.740.8-0.740.80.640.960.810.820.90.840.740.760.430.990.740.97-0.350.810.990.450.740.96
0.960.880.110.990.8-0.41.00.960.721.00.660.950.850.980.970.040.740.990.71-0.310.990.790.260.860.9
-0.61-0.69-0.58-0.35-0.74-0.4-0.39-0.23-0.87-0.41-0.43-0.6-0.4-0.28-0.43-0.74-0.8-0.32-0.860.38-0.48-0.78-0.13-0.26-0.62
0.960.890.140.980.81.0-0.390.960.721.00.720.960.850.980.960.00.750.990.71-0.330.980.790.340.860.91
0.870.76-0.150.980.640.96-0.230.960.570.960.530.860.820.950.96-0.140.580.970.53-0.270.950.640.140.870.79
0.860.890.530.680.960.72-0.870.720.570.730.660.840.780.650.710.560.970.670.97-0.40.770.970.250.660.91
0.970.890.120.990.811.0-0.411.00.960.730.680.960.850.980.970.040.750.990.72-0.320.990.80.290.850.91
0.740.750.590.580.820.66-0.430.720.530.660.680.810.640.640.590.020.780.610.76-0.30.630.760.860.620.81
0.990.950.320.920.90.95-0.60.960.860.840.960.810.820.90.930.160.870.910.85-0.380.950.890.440.80.96
0.840.770.110.850.840.85-0.40.850.820.780.850.640.820.830.840.090.80.840.71-0.320.850.840.20.970.89
0.920.850.10.980.740.98-0.280.980.950.650.980.640.90.830.93-0.020.680.990.64-0.280.950.720.270.840.87
0.940.82-0.020.970.760.97-0.430.960.960.710.970.590.930.840.930.020.720.950.68-0.290.990.780.170.850.84
0.250.370.570.010.430.04-0.740.0-0.140.560.040.020.160.09-0.020.020.510.00.6-0.030.080.48-0.17-0.10.29
0.880.90.590.680.990.74-0.80.750.580.970.750.780.870.80.680.720.510.690.99-0.340.760.990.410.690.93
0.930.860.051.00.740.99-0.320.990.970.670.990.610.910.840.990.950.00.690.65-0.280.970.730.220.860.87
0.870.90.650.650.970.71-0.860.710.530.970.720.760.850.710.640.680.60.990.65-0.340.730.970.410.60.91
-0.35-0.31-0.2-0.28-0.35-0.310.38-0.33-0.27-0.4-0.32-0.3-0.38-0.32-0.28-0.29-0.03-0.34-0.28-0.34-0.33-0.33-0.15-0.26-0.37
0.960.880.080.980.810.99-0.480.980.950.770.990.630.950.850.950.990.080.760.970.73-0.330.810.210.840.89
0.910.890.50.740.990.79-0.780.790.640.970.80.760.890.840.720.780.480.990.730.97-0.330.810.370.740.94
0.340.370.610.170.450.26-0.130.340.140.250.290.860.440.20.270.17-0.170.410.220.41-0.150.210.370.220.42
0.80.72-0.050.860.740.86-0.260.860.870.660.850.620.80.970.840.85-0.10.690.860.6-0.260.840.740.220.83
0.960.960.440.870.960.9-0.620.910.790.910.910.810.960.890.870.840.290.930.870.91-0.370.890.940.420.83
Click cells to compare fundamentals

Eyebright Medical Account Relationship Matchups

Eyebright Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets685.8M1.6B2.0B2.2B3.1B3.2B
Short Long Term Debt Total7.7M894.5K154.8M162.8M187.2M196.6M
Other Current Liab21.9M74.9M133.9M133.9M137.3K130.4K
Total Current Liabilities23.1M77.1M139.4M147.7M377.8M396.7M
Total Stockholder Equity617.6M1.5B1.7B1.9B2.1B1.2B
Property Plant And Equipment Net183.1M267.1M558.7M674.2M1.3B1.3B
Net Debt(195.4M)(536.8M)(318.0M)(192.1M)(172.9M)(181.5M)
Retained Earnings2.5M90.0M213.5M391.4M647.2M679.5M
Accounts Payable280.9K2.2M5.6M13.9M49.0M51.5M
Cash196.3M536.8M472.9M354.9M536.7M308.0M
Non Current Assets Total351.3M492.4M928.9M1.2B2.0B2.1B
Non Currrent Assets Other42.2M87.2M86.2M317.6M170.0M107.0M
Cash And Short Term Investments196.3M537.1M473.4M836.9M962.4M1.0B
Common Stock Shares Outstanding78.5M89.4M105.1M105.3M189.5M106.7M
Liabilities And Stockholders Equity685.8M1.6B2.0B2.2B2.6B2.7B
Non Current Liabilities Total15.1M13.8M168.0M176.6M328.1M344.5M
Inventory60.8M59.1M56.0M78.8M181.4M190.4M
Other Current Assets12.9M466.6M504.1M11.3M36.5M34.6M
Other Stockholder Equity536.2M1.3B1.4B1.4B1.6B845.9M
Total Liab38.3M90.9M307.5M324.3M705.9M741.1M
Total Current Assets334.5M1.1B1.1B1.1B1.0B718.5M
Intangible Assets100.6M112.9M127.8M140.3M252.2M264.8M
Common Stock78.8M78.8M105.1M105.2M121.0M93.5M

Currently Active Assets on Macroaxis

Other Information on Investing in Eyebright Stock

Balance Sheet is a snapshot of the financial position of Eyebright Medical at a specified time, usually calculated after every quarter, six months, or one year. Eyebright Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Eyebright Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Eyebright currently owns. An asset can also be divided into two categories, current and non-current.